IND submission

Related by string. * In . INS . Ind . Ins . in . ins : R Ind . SIMULATED TRADING PROGRAMS IN . IN NO EVENT . GET KNOBIAS IN REAL . ALLOWED IN CHINA HONG . REMAINS IN EFFECT UNTIL / SUBMISSION . submissions . Submissions . Submission . SUBMISSIONS : Letters submission form . submission triangle choke . submission guillotine choke . BLA submission . spam submissions . Submission deadline * *

Related by context. Frequent words. (Click for all words.) 71 IND enabling 68 Phase 2a trial 68 Phase 2b study 67 Phase IIa trial 67 NDA submission 66 phase IIb 66 confirmatory Phase III 65 Phase 2b trial 65 Menerba 65 Phase Ib 64 Phase 1b trial 64 phase IIa 64 CoFactor 64 vilazodone 64 Phase Ia 63 Biologics License Application BLA 63 maribavir 63 Phase 2a 63 SILENOR TM 63 Phase IIb clinical 63 talactoferrin 63 Phase IIa clinical 63 Biologics License Application 63 preclinical 62 teduglutide 62 confirmatory Phase 3 62 Investigational 62 methylnaltrexone 62 MOZOBIL 62 Phase IIb 62 Phase 1a 62 Phase 2b clinical 62 HspE7 62 Phase 2a clinical 62 StaphVAX 62 Marketing Authorization Application 62 Zerenex 62 Restanza 61 ONCONASE 61 BCX# 61 Phase III clinical 61 ALN VSP 61 MBP# [001] 61 Phase 1b 61 crofelemer 61 Phenoptin 61 MOR# 61 FavId 61 APF# 61 ANAVEX #-# [003] 61 PXD# 61 PDUFA date 61 Amigal 61 clinical trials 60 ridaforolimus 60 OFIRMEV 60 preclinical studies 60 DAVANAT ® 60 CTCE 60 DR Cysteamine 60 HGS ETR1 60 Rhucin ® 60 Homspera 60 L DOS# 60 alogliptin 60 Complete Response 60 Phase III 60 IMGN# 60 INDs 60 Oracea 60 phase 2a 60 Marketing Authorization Application MAA 60 pivotal Phase III 60 Marqibo 60 MGCD# [001] 60 Phase III clinical trials 60 Phase IIb trial 60 tezampanel 60 multiple ascending dose 60 PS# [001] 60 Phase III trials 60 elagolix 60 OXi# 59 Investigational Device Exemption IDE 59 darinaparsin 59 TRIOLEX 59 CORLUX 59 ofatumumab 59 QRxPharma 59 Phase 2b 59 Viprinex 59 AP# [003] 59 VQD 59 PRX # 59 anticancer agent 59 orally bioavailable 59 LymphoStat B 59 CBLB# 59 DB# [003] 59 BiTE antibody 58 tamibarotene

Back to home page